Office of the Secretary, Interagency Pain Research Coordinating Committee Call for Committee Membership Nominations, 68126-68127 [2023-21761]
Download as PDF
<![CDATA[
68126
Federal Register / Vol. 88, No. 190 / Tuesday, October 3, 2023 / Notices
Place: Eunice Kennedy Shriver National
Institute of Child Health and Human
Development, National Institutes of Health,
6710B Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Ms. Lisa Neal, Committee
Management Officer, Committee
Management Branch, Eunice Kennedy
Shriver National Institute of Child Health
and Human Development, NIH, 6701B,
Rockledge Drive, Room 2208, Bethesda, MD
20892, (301) 204–1830, lisa.neal@nih.gov.
Information is also available on the
Institute’s/Center’s home page: https://
www.nichd.nih.gov/about/advisory/council,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Dated: September 27, 2023.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–21771 Filed 10–2–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: September 27, 2023.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
National Institutes of Health
[FR Doc. 2023–21776 Filed 10–2–23; 8:45 am]
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
ddrumheller on DSK120RN23PROD with NOTICES1
Contact Person: Ryan G. Morris, Ph.D.,
Scientific Review Officer, NIDDK/Scientific
Review Branch, National Institutes of Health,
6707 Democracy Boulevard, Room 7015,
Bethesda, MD 20892–2542, (301) 594–4721,
ryan.morris@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; HIGH IMPACT
NIDDK RC2 APPLICATIONS.
Date: November 3, 2023.
Time: 3:30 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
NIDDK, Democracy II, Suite 7000A, 6707
Democracy Boulevard, Bethesda, MD 20892
(Virtual Meeting).
VerDate Sep<11>2014
20:04 Oct 02, 2023
Jkt 262001
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; Avenir
Award Program for Chemistry and
Pharmacology of Substance Use Disorders.
Date: January 10, 2024.
Time: 9:45 a.m. to 5:45 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Health,
National Institute on Drug Abuse, 301 North
Stonestreet Avenue, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Marisa Srivareerat, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Office of Extramural Policy, National
Institute on Drug Abuse, NIH, 301 North
Stonestreet Avenue, MSC 6021, Bethesda,
MD 20892, (301) 435–1258,
marisa.srivareerat@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.277, Drug Abuse Scientist
Development Award for Clinicians, Scientist
Development Awards, and Research Scientist
Awards; 93.278, Drug Abuse National
Research Service Awards for Research
Training; 93.279, Drug Abuse and Addiction
Frm 00033
Fmt 4703
Sfmt 4703
Dated: September 28, 2023.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–21815 Filed 10–2–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Secretary, Interagency
Pain Research Coordinating
Committee Call for Committee
Membership Nominations
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
The Department of Health and
Human Services (HHS) (Department)
has created the Interagency Pain
Research Coordinating Committee
(IPRCC) and is seeking nominations for
this committee.
DATES: Nominations are due by 5 p.m.
ET on November 01, 2023.
ADDRESSES: Nominations must be
submitted through the webform on the
IPRCC website: https://
www.surveymonkey.com/r/IPRCCnomination-form.
FOR FURTHER INFORMATION CONTACT:
Linda Porter, porterl@ninds.nih.gov or
301–451–4460.
SUPPLEMENTARY INFORMATION: As
specified in Public Law 111–148
(‘‘Patient Protection and Affordable Care
Act’’) the Committee will:
(A) develop a summary of advances in
pain care research supported or
conducted by the Federal agencies
relevant to the diagnosis, prevention,
and treatment of pain and diseases and
disorders associated with pain;
(B) identify critical gaps in basic and
clinical research on the symptoms and
causes of pain;
(C) make recommendations to ensure
that the activities of the National
Institutes of Health and other Federal
agencies are free of unnecessary
duplication of effort;
(D) make recommendations on how
best to disseminate information on pain
care; and (e) make recommendations on
how to expand partnerships between
public entities and private entities to
expand collaborative, cross-cutting
research.
Membership on the committee will
include six (6) non-Federal members
from among scientists, physicians, and
other health professionals and six (6)
SUMMARY:
National Institute on Drug Abuse;
Notice of Closed Meeting
PO 00000
Research Programs, National Institutes of
Health, HHS)
E:\FR\FM\03OCN1.SGM
03OCN1
Federal Register / Vol. 88, No. 190 / Tuesday, October 3, 2023 / Notices
non-Federal members of the general
public who are representatives of
leading research, advocacy, and service
organizations for individuals with painrelated conditions. Members will serve
overlapping three year terms. It is
anticipated that the committee will meet
at least once a year.
The Department strives to ensure that
the membership of HHS Federal
advisory committees is fairly balanced
in terms of points of view represented
and the committee’s function. Every
effort is made to ensure that the views
of diverse ethnic and racial groups and
people with disabilities are represented
on HHS Federal advisory committees,
and the Department therefore,
encourages nominations of qualified
candidates from these groups. The
Department also encourages geographic
diversity in the composition of the
Committee. Appointment to this
Committee shall be made without
discrimination on the basis of age, race,
ethnicity, gender, sexual orientation,
disability, and cultural, religious, or
socioeconomic status.
The Department is soliciting
nominations for two non-federal
members from among scientists,
physicians, and other health
professionals and for two non-federal
members of the general public who
represent a leading research, advocacy,
or service organization for people with
pain-related conditions. These
candidates will be considered to fill
positions opened through completion of
current member terms. Nominations are
due by 5:00 p.m. ET on November 01,
2023, using the IPRCC nomination
webform: https://
www.surveymonkey.com/r/IPRCCnomination-form.
More information about the IPRCC is
available at https://www.iprcc.nih.gov/.
Dated: September 27, 2023.
Walter J. Koroshetz,
Director, National Institute of Neurological
Disorders and Stroke, National Institutes of
Health.
[FR Doc. 2023–21761 Filed 10–2–23; 8:45 am]
BILLING CODE 4140–01–P
ddrumheller on DSK120RN23PROD with NOTICES1
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
VerDate Sep<11>2014
20:04 Oct 02, 2023
Jkt 262001
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Clinical Trial
Implementation Cooperative Agreement (U01
Clinical Trial Required).
Date: October 30, 2023.
Time: 1:00 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3E71,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Ann Marie M. Brighenti,
Ph.D., Scientific Review Officer, Scientific
Review Program, Division of Extramural
Activities, National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3E71,
Rockville, MD 20852, 301–761–3100,
AnnMarie.Cruz@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: September 26, 2023.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–21743 Filed 10–2–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
68127
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Clinical Trial
Planning Grants (R34 Clinical Trial Not
Allowed) and NIAID SBIR Phase II Clinical
Trial Implementation Cooperative Agreement
(U44 Clinical Trial Required).
Date: December 5, 2023.
Time: 11:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3E71,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Samita Andreansky, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
Fishers Lane, Room 3E71, Rockville, MD
20852, 240–669–2915, samita.andreansky@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: September 27, 2023.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–21770 Filed 10–2–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meetings
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Catalyze Enabling Technologies.
Date: December 4, 2023.
Time: 10:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
E:\FR\FM\03OCN1.SGM
03OCN1
]]>Agencies
[Federal Register Volume 88, Number 190 (Tuesday, October 3, 2023)]
[Notices]
[Pages 68126-68127]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-21761]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Secretary, Interagency Pain Research Coordinating
Committee Call for Committee Membership Nominations
AGENCY: National Institutes of Health, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Department of Health and Human Services (HHS) (Department)
has created the Interagency Pain Research Coordinating Committee
(IPRCC) and is seeking nominations for this committee.
DATES: Nominations are due by 5 p.m. ET on November 01, 2023.
ADDRESSES: Nominations must be submitted through the webform on the
IPRCC website: https://www.surveymonkey.com/r/IPRCC-nomination-form.
FOR FURTHER INFORMATION CONTACT: Linda Porter, [email protected] or
301-451-4460.
SUPPLEMENTARY INFORMATION: As specified in Public Law 111-148
(``Patient Protection and Affordable Care Act'') the Committee will:
(A) develop a summary of advances in pain care research supported
or conducted by the Federal agencies relevant to the diagnosis,
prevention, and treatment of pain and diseases and disorders associated
with pain;
(B) identify critical gaps in basic and clinical research on the
symptoms and causes of pain;
(C) make recommendations to ensure that the activities of the
National Institutes of Health and other Federal agencies are free of
unnecessary duplication of effort;
(D) make recommendations on how best to disseminate information on
pain care; and (e) make recommendations on how to expand partnerships
between public entities and private entities to expand collaborative,
cross-cutting research.
Membership on the committee will include six (6) non-Federal
members from among scientists, physicians, and other health
professionals and six (6)
[[Page 68127]]
non-Federal members of the general public who are representatives of
leading research, advocacy, and service organizations for individuals
with pain-related conditions. Members will serve overlapping three year
terms. It is anticipated that the committee will meet at least once a
year.
The Department strives to ensure that the membership of HHS Federal
advisory committees is fairly balanced in terms of points of view
represented and the committee's function. Every effort is made to
ensure that the views of diverse ethnic and racial groups and people
with disabilities are represented on HHS Federal advisory committees,
and the Department therefore, encourages nominations of qualified
candidates from these groups. The Department also encourages geographic
diversity in the composition of the Committee. Appointment to this
Committee shall be made without discrimination on the basis of age,
race, ethnicity, gender, sexual orientation, disability, and cultural,
religious, or socioeconomic status.
The Department is soliciting nominations for two non-federal
members from among scientists, physicians, and other health
professionals and for two non-federal members of the general public who
represent a leading research, advocacy, or service organization for
people with pain-related conditions. These candidates will be
considered to fill positions opened through completion of current
member terms. Nominations are due by 5:00 p.m. ET on November 01, 2023,
using the IPRCC nomination webform: https://www.surveymonkey.com/r/IPRCC-nomination-form.
More information about the IPRCC is available at https://www.iprcc.nih.gov/.
Dated: September 27, 2023.
Walter J. Koroshetz,
Director, National Institute of Neurological Disorders and Stroke,
National Institutes of Health.
[FR Doc. 2023-21761 Filed 10-2-23; 8:45 am]
BILLING CODE 4140-01-P
